A detailed history of California State Teachers Retirement System transactions in Inhibrx, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 22,593 shares of INBX stock, worth $320,142. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,593
Previous 23,150 2.41%
Holding current value
$320,142
Previous $879,000 10.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$32.76 - $39.56 $18,247 - $22,034
-557 Reduced 2.41%
22,593 $789,000
Q4 2023

Feb 13, 2024

SELL
$14.5 - $38.0 $109,533 - $287,052
-7,554 Reduced 24.6%
23,150 $879,000
Q3 2023

Nov 14, 2023

SELL
$15.75 - $26.31 $58,794 - $98,215
-3,733 Reduced 10.84%
30,704 $563,000
Q2 2023

Aug 21, 2023

SELL
$16.96 - $27.82 $10,701 - $17,554
-631 Reduced 1.8%
34,437 $893,000
Q1 2023

May 09, 2023

BUY
$18.45 - $27.14 $31,438 - $46,246
1,704 Added 5.11%
35,068 $661,000
Q4 2022

Feb 14, 2023

BUY
$20.18 - $33.33 $34,023 - $56,194
1,686 Added 5.32%
33,364 $822,000
Q3 2022

Nov 18, 2022

SELL
$11.58 - $24.73 $1,007 - $2,151
-87 Reduced 0.27%
31,678 $569,000
Q2 2022

Aug 15, 2022

BUY
$8.52 - $25.26 $96,148 - $285,059
11,285 Added 55.1%
31,765 $361,000
Q1 2022

May 16, 2022

SELL
$19.89 - $43.18 $53,265 - $115,636
-2,678 Reduced 11.56%
20,480 $456,000
Q4 2021

Feb 15, 2022

BUY
$26.75 - $46.02 $8,961 - $15,416
335 Added 1.47%
23,158 $1.01 Million
Q3 2021

Nov 15, 2021

SELL
$25.18 - $37.81 $394,369 - $592,180
-15,662 Reduced 40.7%
22,823 $760,000
Q2 2021

Aug 16, 2021

BUY
$14.69 - $27.52 $384,775 - $720,831
26,193 Added 213.09%
38,485 $1.06 Million
Q4 2020

Feb 16, 2021

BUY
$15.96 - $50.0 $196,180 - $614,600
12,292 New
12,292 $405,000

Others Institutions Holding INBX

About Inhibrx, Inc.


  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $553M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.